According to the Zhitong Finance App, Zhongzhi Pharmaceutical (03737) announced interim results for the six months ended June 30, 2026. The group achieved revenue of 790 million yuan (RMB, same below), a year-on-year decrease of 10.28%; profit attributable to owners of the parent company was 9.116 million yuan, an increase of 3.79% over the previous year; and a basic profit of 1.1 points per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.